Does Scholar Rock (SRRK) Offer Long-Term Value After Recent Share Price Weakness?

Simply Wall St.03-20

If you are wondering whether Scholar Rock Holding's current share price matches what the business may be worth, you will want to look closely at how its value stacks up across different methods. The ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620275556?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-03-20 02:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620275556","market":"us","top_or_hot":-1,"title":"Does Scholar Rock (SRRK) Offer Long-Term Value After Recent Share Price Weakness?","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Scholar Rock Holding's current share price matches what the business may be worth, you will want to look closely at how its value stacks up across different methods. The ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/does-scholar-rock-srrk-offer-long-term-value-after-recent-sh\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Does Scholar Rock (SRRK) Offer Long-Term Value After Recent Share Price Weakness?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoes Scholar Rock (SRRK) Offer Long-Term Value After Recent Share Price Weakness?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-20 02:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/does-scholar-rock-srrk-offer-long-term-value-after-recent-sh><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Scholar Rock Holding's current share price matches what the business may be worth, you will want to look closely at how its value stacks up across different methods. The ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/does-scholar-rock-srrk-offer-long-term-value-after-recent-sh\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SRRK","symbol_name":"Scholar Rock Holding Corp","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/does-scholar-rock-srrk-offer-long-term-value-after-recent-sh","article_id":"2620275556","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/does-scholar-rock-srrk-offer-long-term-value-after-recent-sh","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2620275556","pubTimestamp":1773944040,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Scholar Rock Holding's current share price matches what the business may be worth, you will want to look closely at how its value stacks up across different methods.\nThe stock closed at US$39.79, with returns of a 7.9% decline over 7 days, a 13.5% decline over 30 days, a 7.0% decline year to date, a 17.1% gain over 1 year, and a very large 3-year gain of 334.9%, alongside a 22.4% loss over 5 years.\nThose mixed returns hint that sentiment around Scholar Rock...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"SRRK":"Scholar Rock Holding Corp","BK4139":"生物科技","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc"},"translate_title":"Scholar Rock(SRRK)在近期股价疲软后是否提供长期价值？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"SRRK":1.5},"content_text":"If you are wondering whether Scholar Rock Holding's current share price matches what the business may be worth, you will want to look closely at how its value stacks up across different methods. The stock closed at US$39.79, with returns of a 7.9% decline over 7 days, a 13.5% decline over 30 days, a 7.0% decline year to date, a 17.1% gain over 1 year, and a very large 3-year gain of 334.9%, alongside a 22.4% loss over 5 years. Those mixed returns hint that sentiment around Scholar Rock Holding has shifted more than once, and recent prices may not tell the full story. Evergreen coverage like this is designed to give you a steadier reference point than short term price swings. Scholar Rock Holding currently has a valuation score of 3/6, which reflects the number of checks where it screens as undervalued. The sections that follow will walk through the main valuation approaches, with a broader way to think about value saved for the end of the article.  Find out why Scholar Rock Holding's 17.1% return over the last year is lagging behind its peers. AdvertisementApproach 1: Scholar Rock Holding Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model takes estimates of a company’s future cash flows and discounts them back to today’s dollars. The aim is to show what the entire stream of cash could be worth in present value terms. For Scholar Rock Holding, the latest twelve month Free Cash Flow is a loss of about $300.6 million. Analysts provide detailed Free Cash Flow estimates out to 2030, and Simply Wall St extrapolates further years using its 2 Stage Free Cash Flow to Equity model. Within this framework, projected Free Cash Flow for 2030 is $235.7 million, and there is a path of yearly projections between 2026 and 2035 that feed into the calculation. When all those projected cash flows are discounted back using this model, the estimated intrinsic value comes out at about $174.94 per share. Compared with the recent share price of $39.79, this implies an intrinsic discount of roughly 77.3%, which indicates the shares are trading well below this DCF estimate. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Scholar Rock Holding is undervalued by 77.3%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks. SRRK Discounted Cash Flow as at Mar 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Scholar Rock Holding. Approach 2: Scholar Rock Holding Price vs Book (P/B) For companies where earnings are not yet a reliable guide, price to book can be a useful yardstick because it compares what you pay in the market with the accounting value of net assets on the balance sheet. The “right” P/B ratio often reflects how investors weigh growth potential against risk. Higher growth expectations or stronger balance sheets can support a higher normal P/B, while higher risk or weaker profitability can point to a lower one. Scholar Rock Holding currently trades on a P/B of 18.62x. That is well above the broader Biotechs industry average P/B of 2.49x and also above the peer group average of 11.46x, so on simple comparisons the stock appears expensive relative to assets. Simply Wall St’s Fair Ratio is a proprietary estimate of what P/B might be reasonable for Scholar Rock Holding given its earnings profile, growth expectations, profit margins, market cap, risk characteristics and industry. Because it blends all of these company specific factors, it can give a more tailored view than raw comparisons with peers or the sector. Those comparisons only show how the market prices other companies rather than what may be appropriate for this business. Since the Fair Ratio is not currently available, it is not possible to reach a clear conclusion on whether the present 18.62x P/B suggests the shares are overvalued, undervalued, or about right. Result: ABOUT RIGHT NasdaqGS:SRRK P/B Ratio as at Mar 2026 P/B ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies. Upgrade Your Decision Making: Choose your Scholar Rock Holding Narrative Earlier it was mentioned that there is an even better way to think about valuation, and that is where Narratives come in, because on Simply Wall St’s Community page you can attach a clear story about Scholar Rock Holding to your own revenue, earnings and margin assumptions, link that story to a financial forecast and fair value, see how your view compares with others on the platform, and quickly spot whether your Fair Value suggests Scholar Rock Holding is expensive or cheap relative to the current price, with those Narratives updating automatically as new news or earnings arrive so that, for example, one investor might build a bullish Narrative around global SMA adoption, broader neuromuscular indications and a Fair Value closer to the higher analyst target of US$70.00, while another focuses on regulatory and execution risks and anchors nearer the lower US$47.00 target. Do you think there's more to the story for Scholar Rock Holding? Head over to our Community to see what others are saying! NasdaqGS:SRRK 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620275556","isCrawlerRequest":true}